ask="1.4000"
ask_size="200"
average_daily_volume="97992"
bid="0.7000"
bid_size="200"
book_value="0.6940"
change="+0.0179"
change_from_200_day_moving_average="-0.2251"
change_from_50_day_moving_average="0.0549"
change_from_52_week_high="-6.6921"
change_From_52_week_low="0.3377"
change_in_percent="+1.4435%"
close="1.2579"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.1560"
ebitda="-17.60M"
eps_estimate_current_year="-1.0900"
eps_estimate_next_quarter="-0.2900"
eps_estimate_next_year="-0.8200"
ex_dividend_date="N/A"
float_shares="6119000"
high="1.3000"
high_52_weeks="7.9500"
last_trade_date="2/9/2017"
last_trade_price="1.2579"
last_trade_size="200"
last_trade_time="3:48pm"
low="1.2100"
low_52_weeks="0.9202"
market_capitalization="20.62M"
moving_average_200_day="1.4830"
moving_average_50_day="1.2030"
name="Bioblast Pharma Ltd."
notes="N/A"
one_year_target_price="9.0000"
open="1.2200"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="-15.1764%"
percent_change_from_50_day_moving_average="+4.5662%"
percent_change_from_52_week_high="-84.1774%"
percent_change_from_52_week_low="+36.6985%"
previous_close="1.2400"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.7867"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="16391000"
short_ratio="2.6800"
stock_exchange="NGM"
symbol="ORPN"
volume="118030"
weeks_range_52="0.9202 - 7.9500"
